Prospective Study of Outcomes After Percutaneous Biliary Drainage for Malignant Biliary Obstruction

Overview

Journal Ann Surg Oncol

Publisher Springer

Specialty Oncology

Date 2010 Apr 2

PMID 20358300

Citations 30

Authors

P C Robson

N Heffernan

M Gonen

R Thornton

L A Brody

R Holmes

K T Brown

A M Covey

D Fleischer

G I Getrajdman

W Jarnagin

C Sofocleous

L Blumgart

M DAngelica

Affiliations

Soon will be listed here.

Abstract

Background: Percutaneous biliary drainage (PBD) is used to relieve malignant bile duct obstruction (MBO) when endoscopic drainage is not feasible. Little is known about the effects of PBD on the quality of life (QoL) in patients with MBO. The aim of this study was to evaluate changes in QoL and pruritus after PBD and to explore the variables that impact these changes.

Materials And Methods: Eligible patients reported their QoL and pruritus before and after PBD using the Functional Assessment of Cancer Therapy-Hepatobiliary instrument (FACT-HS) and the Visual Analog Scale for Pruritus (VASP). Instruments were completed preprocedure and at 1 and 4 weeks following PBD.

Results: A total of 109 (60 male/49 female) patients enrolled; 102 (94%) had unresectable disease. PBD was technically successful (hepatic ducts cannulated at the conclusion of procedure) in all patients. There were 2 procedure-related deaths. All-cause mortality was 10% (N = 11) at 4 weeks and 28% (N = 31) at 8 weeks post-PBD with a median survival of 4.74 months. The mean FACT-HS scores declined significantly (P < .01) over time (101.3, 94.8, 94.7 at baseline, 1 week, 4 weeks, respectively). The VASP scores showed significant improvement at 1 week with continued improvement at 4 weeks (P < .01).

Conclusions: PBD improves pruritus but not QoL in patients with MBO and advanced malignancy. There is high early mortality in this population.

Citing Articles

The updated Asia-Pacific consensus statement on the role of endoscopic management in malignant hilar biliary obstruction.

Angsuwatcharakon P, Kulpatcharapong S, Chuncharunee A, Khor C, Devereaux B, Moon J Endosc Int Open. 2024; 12(9):E1065-E1074.

PMID: 39285860 PMC: 11405119. DOI: 10.1055/a-2366-7302.

Risk factors for acute pancreatitis post percutaneous transhepatic biliary stenting in patients with distal malignant obstruction.

Zhang C, Liu Y, Zhou X, Sun Z, Li Y, Hou R Quant Imaging Med Surg. 2024; 14(9):6508-6516.

PMID: 39281182 PMC: 11400659. DOI: 10.21037/qims-24-431.

Clinical Outcomes of Biliary Drainage in Patients with Malignant Biliary Obstruction Caused by Colorectal Cancer Metastases.

Kastelijn J, Moons L, Kist J, Prince J, van Leeuwen M, Koopman M J Gastrointest Cancer. 2022; 54(2):564-573.

PMID: 35608755 PMC: 10435637. DOI: 10.1007/s12029-022-00834-y.

Percutaneous transhepatic drainage is safe and effective in biliary obstruction-A single-center experience of 599 patients.

Kokas B, Szijarto A, Farkas N, Ujvary M, Mori S, Kalocsai A PLoS One. 2021; 16(11):e0260223.

PMID: 34793565 PMC: 8601527. DOI: 10.1371/journal.pone.0260223.

Indian College of Radiology and Imaging Evidence-Based Guidelines for Percutaneous Image-Guided Biliary Procedures.

Madhusudhan K, Jineesh V, Keshava S Indian J Radiol Imaging. 2021; 31(2):421-440.

PMID: 34556927 PMC: 8448229. DOI: 10.1055/s-0041-1734222.

References

Abraham N, Barkun J, Barkun A . Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc. 2002; 56(6):835-41. DOI: 10.1067/mge.2002.129868. View

Yosipovitch G, Goon A, Wee J, Chan Y, Zucker I, Goh C . Itch characteristics in Chinese patients with atopic dermatitis using a new questionnaire for the assessment of pruritus. Int J Dermatol. 2002; 41(4):212-6. DOI: 10.1046/j.1365-4362.2002.01460.x. View

Blazeby J, Nicklin J, Brookes S, Winstone K, Alderson D . Feasibility of quality of life assessment in patients with upper gastrointestinal tract cancer. Br J Cancer. 2003; 89(3):497-501. PMC: 2394377. DOI: 10.1038/sj.bjc.6601146. View

Covey A, Brown K . Palliative percutaneous drainage in malignant biliary obstruction. Part 1: indications and preprocedure evaluation. J Support Oncol. 2006; 4(6):269-73. View

List M, DAntonio L, Cella D, Siston A, Mumby P, Haraf D . The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity. Cancer. 1996; 77(11):2294-301. DOI: 10.1002/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>3.0.CO;2-S. View

Ferrucci Jr J, Mueller P, Harbin W . Percutaneous transhepatic biliary drainage: technique, results, and applications. Radiology. 1980; 135(1):1-13. DOI: 10.1148/radiology.135.1.7360943. View

Pinol V, Castells A, Bordas J, Real M, Llach J, Montana X . Percutaneous self-expanding metal stents versus endoscopic polyethylene endoprostheses for treating malignant biliary obstruction: randomized clinical trial. Radiology. 2002; 225(1):27-34. DOI: 10.1148/radiol.2243011517. View

Sun V, Ferrell B, Juarez G, Wagman L, Yen Y, Chung V . Symptom concerns and quality of life in hepatobiliary cancers. Oncol Nurs Forum. 2008; 35(3):E45-52. DOI: 10.1188/08.ONF.E45-E52. View

Jarnagin W, Burke E, Powers C, Fong Y, Blumgart L . Intrahepatic biliary enteric bypass provides effective palliation in selected patients with malignant obstruction at the hepatic duct confluence. Am J Surg. 1998; 175(6):453-60. DOI: 10.1016/s0002-9610(98)00084-1. View

10.

Ward W, Hahn E, Mo F, Hernandez L, Tulsky D, Cella D . Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res. 1999; 8(3):181-95. DOI: 10.1023/a:1008821826499. View

11.

Saluja S, Gulati M, Garg P, Pal H, Pal S, Sahni P . Endoscopic or percutaneous biliary drainage for gallbladder cancer: a randomized trial and quality of life assessment. Clin Gastroenterol Hepatol. 2008; 6(8):944-950.e3. DOI: 10.1016/j.cgh.2008.03.028. View

12.

Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta K . Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology. 1998; 50(6):920-8. DOI: 10.1016/S0090-4295(97)00459-7. View

13.

Brady M, Cella D, Mo F, Bonomi A, Tulsky D, Lloyd S . Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol. 1997; 15(3):974-86. DOI: 10.1200/JCO.1997.15.3.974. View

14.

Heffernan N, Cella D, Webster K, Odom L, Martone M, Passik S . Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire. J Clin Oncol. 2002; 20(9):2229-39. DOI: 10.1200/JCO.2002.07.093. View

15.

van Dijkum E, Kuhlmann K, Terwee C, Obertop H, de Haes J, Gouma D . Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma. Br J Surg. 2005; 92(4):471-7. DOI: 10.1002/bjs.4887. View

16.

Kaskarelis I, Papadaki M, Papageorgiou G, Limniati M, Malliaraki N, Piperopoulos P . Long-term follow-up in patients with malignant biliary obstruction after percutaneous placement of uncovered wallstent endoprostheses. Acta Radiol. 1999; 40(5):528-33. DOI: 10.3109/02841859909175579. View

17.

Liu C, Lo C, Lai E, Fan S . Endoscopic retrograde cholangiopancreatography and endoscopic endoprosthesis insertion in patients with Klatskin tumors. Arch Surg. 1998; 133(3):293-6. DOI: 10.1001/archsurg.133.3.293. View

18.

Wahlgren C . Measurement of itch. Semin Dermatol. 1995; 14(4):277-84. DOI: 10.1016/s1085-5629(05)80048-3. View

19.

Steel J, Baum A, Carr B . Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial infusion of Cisplatin versus 90-Yttrium microspheres (Therasphere). Psychooncology. 2004; 13(2):73-9. DOI: 10.1002/pon.725. View

20.

van Delden O, Lameris J . Percutaneous drainage and stenting for palliation of malignant bile duct obstruction. Eur Radiol. 2007; 18(3):448-56. DOI: 10.1007/s00330-007-0796-6. View